Member Info for chrishutch

morning*

good to see the buyers this moring.

A lovely string of buying there! amounts larger than before too.

I know someone who just bought a chunk of stock and the buy is not printed yet.

Although Integumen does collaborate with the below

Bradford University
Liverpool University
Sheffield Hallam University
University College London
University College Cork

But I do not think this is related to SKIN.

I was happy with my buy today!

has to go up from this level. you would think. Worth the punt in my book.

anyone else adding some?

at 0.41 seems like a gift.

Anyone think this is a major investor loading up. Fits the bill to some extent.

The chart is starting to look a lot more positive, isn't it.

Still quietly accumulating here, imagine how noisy this is going to be when news lands.

Be nice to see this move up. 3.72 is steal.

Good spot 1750mk1 20 billion is huge. If you add all these potential market sizes that the company is trying to exploit. You start to see the potential the company could make with any one of them.

20 billion wound care
24.9 Billion Sun Care Market

I have absolutely no idea how big the lab-grown human skin or rather ending animal testing market is... but I would guess many many multiples.

Where do people see this in six months?

There are so many reasons for new investors to start buying SKIN now. It is one of the most exciting plays on the market right now. Tomorrow's world technology and science which has left the competition wondering wtf they have been doing.

* Labgrown human skin that can be tested on instead of testing on animals
* Only commercially available option for its type.
* Exploiting technologies such as Artificial Intelligence
* Human cloning
* Ethical investment
* Exploiting CBD market
* Cutting edge Woundcare products
* Expanding by 100% to accommodate the rate of growth
*Currently negotiating further contracts. (8 CBD we know of and others)
*Fully funded - The growth of the Company has been so well supported and received by the market that all corporate activity has been achieved, funding in place to accommodate the continued growth.
* meeting its objective of increasing the average revenue per client as it evolves into a multiple revenue stream product and services company
* Four Blue-Chip (US and EU) client agreements signed
* owns 9.34% of Cellulac plc
* Company moving forward at a rapid pace.
* Major relationships already built with billion-dollar companies
* Sales routes for products already in place in multiple countries
* laws changing to force companies to stop beauty and pharmaceuticals testing on animals.
* Strong, dynamic and driven board
* CEO is an owner of company/major investor
* Current price is a gift.

Then there is the fact they are constantly adding new developments using their existing technology to develop this such as http://labskintattoo.com/ which I suspect will lead to an acne, psoriasis, eczema, dandruff, etc version.

I really urge all investors to take a look at Integumen and consider adding it to your portfolio. It has the potential to really be something quite special. I am sharing my notes below with you but they really are out of date despite them only being a month old because the speed at which the company is growing.

https://drive.google.com/file/d/1x6PYfrCrRbKJ58NZ4ROvQilL91_GvkZp/view
https://twitter.com/MrChrisHutch/status/1146315299383328768?s=20

Love all the speculation, haha.

It closed up. Was NT into the close, the 100k that shows as uncrossing was sat on the book waiting for ages without going through in the auction period. Felt like they wanted shares for a lot of the afternoon.

I am not sure how you 'corrected' you gave a view too.

I said 'Notice the code 1 - be nice if it was a holdings'

Code 1 as in 1 share traded - could be something, could be nothing but 1 share was traded. So I do not understand how you could correct me.

Its NT????????